Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.

Allin KH, Bojesen SE, Nordestgaard BG.

J Clin Oncol. 2009 May 1;27(13):2217-24. doi: 10.1200/JCO.2008.19.8440. Epub 2009 Mar 16.

PMID:
19289618
2.

C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease.

van Durme YM, Verhamme KM, Aarnoudse AJ, Van Pottelberge GR, Hofman A, Witteman JC, Joos GF, Brusselle GG, Stricker BH.

Am J Respir Crit Care Med. 2009 Mar 1;179(5):375-82. doi: 10.1164/rccm.200810-1540OC. Epub 2008 Dec 18.

PMID:
19096002
3.

Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial.

Yu YY, Pinsky PF, Caporaso NE, Chatterjee N, Baumgarten M, Langenberg P, Furuno JP, Lan Q, Engels EA.

Arch Intern Med. 2008 Nov 24;168(21):2326-32; discussion 2332. doi: 10.1001/archinte.168.21.2326.

4.

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.

Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR.

Circulation. 2008 Nov 25;118(22):2243-51, 4p following 2251. doi: 10.1161/CIRCULATIONAHA.108.814251. Epub 2008 Nov 9.

5.

Elevated C-reactive protein in atherosclerosis--chicken or egg?

Schunkert H, Samani NJ.

N Engl J Med. 2008 Oct 30;359(18):1953-5. doi: 10.1056/NEJMe0807235. No abstract available.

PMID:
18971498
6.

Genetically elevated C-reactive protein and ischemic vascular disease.

Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG.

N Engl J Med. 2008 Oct 30;359(18):1897-908. doi: 10.1056/NEJMoa0707402.

7.

Inflammation in the development of lung cancer: epidemiological evidence.

Engels EA.

Expert Rev Anticancer Ther. 2008 Apr;8(4):605-15. doi: 10.1586/14737140.8.4.605. Review.

PMID:
18402527
8.

Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease.

Sin DD, Man SF.

Curr Opin Pulm Med. 2008 Mar;14(2):115-21. doi: 10.1097/MCP.0b013e3282f45ffb. Review.

PMID:
18303420
9.

Genetic determinants of C-reactive protein.

Danik JS, Ridker PM.

Curr Atheroscler Rep. 2007 Sep;9(3):195-203. Review.

PMID:
18241613
10.

Inflammation and lung carcinogenesis: applying findings in prevention and treatment.

Peebles KA, Lee JM, Mao JT, Hazra S, Reckamp KL, Krysan K, Dohadwala M, Heinrich EL, Walser TC, Cui X, Baratelli FE, Garon E, Sharma S, Dubinett SM.

Expert Rev Anticancer Ther. 2007 Oct;7(10):1405-21. Review.

PMID:
17944566
11.

A systematic review of the association between circulating concentrations of C reactive protein and cancer.

Heikkilä K, Ebrahim S, Lawlor DA.

J Epidemiol Community Health. 2007 Sep;61(9):824-33. Review.

12.

Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer.

Engels EA, Wu X, Gu J, Dong Q, Liu J, Spitz MR.

Cancer Res. 2007 Jul 1;67(13):6520-7. Epub 2007 Jun 27.

13.

A risk model for prediction of lung cancer.

Spitz MR, Hong WK, Amos CI, Wu X, Schabath MB, Dong Q, Shete S, Etzel CJ.

J Natl Cancer Inst. 2007 May 2;99(9):715-26.

PMID:
17470739
14.

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

Ridker PM, Buring JE, Rifai N, Cook NR.

JAMA. 2007 Feb 14;297(6):611-9. Erratum in: JAMA. 2007 Apr 4;297(13):1433.

PMID:
17299196
15.

C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.

Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, Hofman A, Pols HA, Stricker BH.

J Clin Oncol. 2006 Nov 20;24(33):5216-22.

PMID:
17114654
16.

Lung cancer risk prediction: a tool for early detection.

Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK.

Int J Cancer. 2007 Jan 1;120(1):1-6. Review.

17.

Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers.

Purdue MP, Gold L, Järvholm B, Alavanja MC, Ward MH, Vermeulen R.

Thorax. 2007 Jan;62(1):51-6. Epub 2006 Aug 23.

18.

State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer.

Brody JS, Spira A.

Proc Am Thorac Soc. 2006 Aug;3(6):535-7. Review.

PMID:
16921139
19.

Plasma C-reactive protein and risk of cancer: a prospective study from Greece.

Trichopoulos D, Psaltopoulou T, Orfanos P, Trichopoulou A, Boffetta P.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):381-4.

20.

Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer.

Sin DD, Man SF, McWilliams A, Lam S.

Am J Respir Crit Care Med. 2006 Mar 1;173(5):535-9. Epub 2005 Dec 9.

Supplemental Content

Support Center